APOBEC3B and cancer: Finally, we show that APOBEC3B-induced heteroclitic neoepitope vaccines are effective against different tumor types, growing in different anatomic locations, indicating that this represents a technically simple, widely applicable method to exploit neoepitopes for cancer immunotherapy.